Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1996
03/21/1996CA2132500A1 Methods for predicting the behaviour of breast tumours
03/20/1996EP0702085A1 Recombinant infectious non-segmented negative strand RNA virus
03/20/1996EP0702084A1 Recombinant retroviruses
03/20/1996EP0702083A2 Polypeptides and fusion proteins that contain the UL57 open reading frame or the C-terminus of tegument protein pp150 from HCMV, corresponding oligonucleotides and diagnostic test kits
03/20/1996EP0702028A2 Binding agent for growth factor
03/20/1996EP0701818A2 Therapeutic methods using catalytic antibodies
03/20/1996EP0701696A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
03/20/1996EP0701616A1 Multicistronic expression of recombinant genes in bacterial cells
03/20/1996EP0701613A1 Isolation of mushroom-inducing genes and their use in dna-mediated transformation of edible basidiomycetes
03/20/1996EP0701612A1 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS
03/20/1996EP0701611A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
03/20/1996EP0701610A1 Dna coding for the human thyrotropin-releasing hormone receptor
03/20/1996EP0701607A1 Mammals lacking expression of cd28 transgenic
03/20/1996EP0701606A1 Method of enhancing thrombolysis
03/20/1996EP0701573A1 Genetically engineered immunoglobulins
03/20/1996EP0701572A1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
03/20/1996EP0701570A1 Thermoresistant alpha-1-antitrypsin mutein
03/20/1996EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
03/20/1996EP0701563A1 Gene transfer for treating a connective tissue of a mammalian host
03/20/1996EP0701450A1 Recombinant viruses and their use in gene therapy
03/20/1996EP0701448A1 Amplification of the vitamin b 12? uptake system using polymers
03/20/1996EP0701401A1 Adenoviral vectors including dna encoding lung surfactant protein
03/20/1996EP0571417B1 Combination of igf-i and igfbp for anabolism
03/20/1996EP0456842B1 Medicinal application of m-csf
03/20/1996EP0456686B1 Excretory/secretory antigens of tapeworm (cysticercus cellulosae) for use in immunodiagnosis and vaccine preparation
03/20/1996EP0449973B1 Polypeptide-polymer conjugates active in wound healing
03/20/1996EP0355140B1 Human monoclonal anti-hiv-i-antibodies
03/20/1996EP0280710B1 Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids
03/20/1996CN1119042A Non-denaturing potency assay for bovine somatotropin
03/20/1996CN1119027A Method of controlling insects in plants
03/20/1996CN1119026A Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
03/20/1996CN1119018A Purification of human interleukin-10
03/20/1996CN1118983A Tomato spotted wilt virus
03/19/1996US5500414 Derivatives of peptides usable as inhibitors of bacterial collagenases
03/19/1996US5500412 Selective stimulation and inhibition of receptor signals, wound healing, antitumor agents
03/19/1996US5500366 Polynucleotide encoding T-cell epitopes of the protein TraT
03/19/1996US5500365 Synthetic plant genes
03/19/1996US5500362 Chimeric antibody with specificity to human B cell surface antigen
03/19/1996US5500355 Used for diagnosis of retroviral diseases
03/19/1996US5500354 Genetic engineering
03/19/1996US5500353 Genetic engineering; caulobacter; vaccines
03/19/1996US5500347 Diagnosis of cancerous tumors and determination of their origin
03/19/1996US5500229 Colostrum fraction, a process of preparing it and its use as a supplement in cell culture media
03/19/1996CA2073012C Method for isolating factor viii
03/19/1996CA1338171C Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical
03/17/1996CA2158395A1 Coccidiosis poultry vaccine
03/14/1996WO1996007915A1 Predictive test for hepatitis-b resistance
03/14/1996WO1996007910A1 Diagnostic drug for chlamydia infection
03/14/1996WO1996007754A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
03/14/1996WO1996007747A1 Retroviral vector hybrids and the use thereof for gene transfer
03/14/1996WO1996007745A2 Mycobacteria functional screening and/or expression vectors
03/14/1996WO1996007744A1 A method of improved production of insulin-like growth factor
03/14/1996WO1996007741A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
03/14/1996WO1996007739A2 Interleukin-1 type 3 receptors
03/14/1996WO1996007738A2 Modified human c3 proteins
03/14/1996WO1996007737A1 A novel haemopoietin receptor
03/14/1996WO1996007734A2 Recombinant adenovirus comprising a chimeric penton base protein
03/14/1996WO1996007728A1 Production and secretion of recombinant fibrinogen by yeast
03/14/1996WO1996007673A1 Monocyte chemotaxin inducible proteins
03/14/1996WO1996007425A1 Method of blocking the sec receptor
03/14/1996WO1996007424A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
03/14/1996WO1996007322A1 Method of sensitizing tumor cells with adenovirus e1a
03/14/1996WO1996007313A1 A plant promoter useful for directing the expression of foreign proteins to the plant epidermis
03/14/1996WO1996006168A3 Retinoblastoma protein-interacting zinc finger proteins
03/14/1996WO1996005307A3 17q-linked breast and ovarian cancer susceptibility gene
03/14/1996WO1996005306A3 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
03/14/1996WO1996004378A3 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2
03/14/1996WO1996001615A3 Hepatitis a virus deletion mutants and vaccine formulations containing the same
03/14/1996WO1996001425A3 Assay for inhibitors of dp-1 and other dp proteins
03/14/1996WO1995035376A3 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains
03/14/1996WO1995035373A3 Nucleic acid molecules encoding human contactin
03/14/1996WO1995034651A3 Corticotropin-releasing factor2 receptors
03/14/1996DE19532495A1 Verfahren zum Reinigen von Hirudin A method for cleaning of hirudin
03/14/1996DE19503952A1 Retrovirale Vektorhybride und deren Verwendung zum Gentransfer Retroviral vector hybrids and their use for gene transfer
03/14/1996CA2199609A1 Interleukin-1 type 3 receptors
03/14/1996CA2199265A1 Method of sensitizing tumor cells with adenovirus e1a
03/14/1996CA2199180A1 Method of blocking the sec receptor
03/14/1996CA2198928A1 Production and secretion of recombinant fibrinogen by yeast
03/14/1996CA2198870A1 A plant promoter useful for directing the expression of foreign proteins to the plant epidermis
03/14/1996CA2198861A1 Recombinant adenovirus comprising a chimeric penton base protein
03/14/1996CA2198707A1 Predictive test for hepatitis-b resistance
03/14/1996CA2198621A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
03/14/1996CA2198018A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
03/14/1996CA2197888A1 Modified human c3 proteins
03/14/1996CA2197873A1 A novel haemopoietin receptor
03/13/1996EP0701127A1 Method of testing neurotoxicity of poliovirus vaccine
03/13/1996EP0700999A2 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
03/13/1996EP0700998A1 Recombinant mersacidin and a method for production
03/13/1996EP0700997A1 Production in bacteria and yeast of hemoglobin and analogues thereof
03/13/1996EP0700933A1 Microsphere-based biotin-latex, process for the manufacture of such microspheres and use thereof as biological detecting agents
03/13/1996EP0700929A2 Peptide derived from cedar pollen allergens and uses thereof
03/13/1996EP0700928A1 Nucleic acid-binding oligomers for therapy and diagnostics
03/13/1996EP0700683A1 Insulin analog formulations
03/13/1996EP0700447A1 Fluorescence energy transfer substrates
03/13/1996EP0700446A1 Antibodies specific for dcc gene product
03/13/1996EP0700445A1 Stress proteins and uses therefor
03/13/1996EP0700444A1 Immunotoxins comprising gelonin and an antibody
03/13/1996EP0700442A1 Immortalized human cell lines containing exogenous cytochrome p450 genes
03/13/1996EP0700441A1 Multiple sclerosis virus
03/13/1996EP0700440A1 Regulator of contact-mediated hemolysin
1 ... 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 ... 2916